Advertisement

Topics

Hikma Pharmaceuticals Limited Company Profile

03:09 EDT 17th October 2018 | BioPortfolio

Hikma is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products..
FDA-approved manufacturing facilities
Proven ability to produce a broad range of pharmaceuticals and dosages, from solid, semi-solid, liquid and injectable pharmaceutical products
Strong R&D capability, with particular expertise in technically challenging products
Sales in more than 30 countries around the world, spanning the USA, Europe and the Middle East and North Africa (MENA), supported by one of the largest sales and marketing forces in the MENA region
Double-digit sales growth since 1996, with over 50% of our sales in the USA

Location

Bayader Wadi SeerPO Box 182400
Amman
11118
Jordan

Contact

Phone: 962 6 580 2900
Fax: 962 6 581 7102
Email: mrkt@hikma.com


News Articles [448 Associated News Articles listed on BioPortfolio]

Hikma launches HIV generic ritonavir in the US

Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) announced on 20 March 2018 that its wholly owned US subsidiary West-Ward Pharmaceuticals Corp had launched generic ritonavir tablets (100 mg) ...

Hikma Pharmaceuticals launches palonosetron hydrochloride injection

Hikma Pharmaceuticals Plc (Hikma) announced that its wholly owned US subsidiary West─Ward Pharmaceuticals Corp. (West─Ward), has launched Palonosetron Hydrochloride (HCl) injection, 0.25mg/2mL.

Biosimilar deals for Hikma and Lupin

Collaborations are once again the way forward when it comes to biosimilars. Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) made a licensing deal with South Korean biotechnology company Celltrion...

Follow-on biologicals deals for Hikma and Lupin

Collaborations are once again the way forward when it comes to biosimilars. Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) made a licensing deal with South Korean biotechnology company Celltrion...

BRIEF — Hikma to sell biosimilar thrombosis drug in MENA region

London-listed Jordanian drugmaker Hikma Pharmaceuticals has signed a licensing agreement with Spanish…

Hikma subsidiary launches palonosetron injection in the US

Hikma Pharmaceuticals announced on Thursday that its wholly-owned US subsidiary West-Ward Pharmaceuticals has launched the palonosetron hydrochloride injection at 0.25mg/2mL. The FTSE 250 company s...

FTSE 250 movers: Hikma Pharmaceuticals rises, Sanne Group falls

(WebFG News) - FTSE 250 - Risers Hikma Pharmaceuticals (HIK) 1,241.00p 4.77% Saga (SAGA) 131.47p 3.20% esure Group (ESUR) 228.00p 3.07% Ultra Electronics Holdings (ULE) 1,363.00p 3.02% Inmarsat (IS...

Hikma Pharma Adds Palonosetron HCI Injection To Its Oncology Portfolio

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Hikma Pharmaceuticals plc (HIK.L, HKMPY.PK) announced that its US subsidiary West-Ward Pharmaceuticals Corp. (West-Ward), has launched Palonosetron Hydrochlori...

PubMed Articles [142 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1412 Associated Companies listed on BioPortfolio]

Hikma Pharmaceuticals

Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals Limited

Hikma is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.. FDA-app...

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, and is the 4th largest pharmaceutical company in the U.S. based on prescriptions filled. To...

More Information about "Hikma Pharmaceuticals Limited" on BioPortfolio

We have published hundreds of Hikma Pharmaceuticals Limited news stories on BioPortfolio along with dozens of Hikma Pharmaceuticals Limited Clinical Trials and PubMed Articles about Hikma Pharmaceuticals Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hikma Pharmaceuticals Limited Companies in our database. You can also find out about relevant Hikma Pharmaceuticals Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record